Navigation Links
Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy
Date:5/16/2008

HOUSTON - Gefitinib, the once-promising drug formerly approved as a second line treatment for lung cancer, also known as Iressa, enhanced the effectiveness of hormonal therapy for the treatment of specific types of metastatic breast cancer, according to a Phase II clinical trial led by researchers at The University of Texas M. D. Anderson Cancer Center.

These findings are surprising and represent the first positive study for Iressa in breast cancer, as well as for the entire class of drugs known as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors, said Massimo Cristofanilli, M.D., the study's principal investigator.

Cristofanilli will present the findings at the American Society for Clinical Oncology's (ASCO) upcoming annual meeting as an oral presentation.

"We initiated this study in 2003 with hopes of reducing the resistance to hormonal therapy," said Cristofanilli. "There was a lot of preclinical work indicating that, in fact, resistance to hormonal therapy is strongly associated with an activated EGFR pathway. Also, EGFR over-expression has been associated with endocrine resistance. If there's a double blockage of the EGFR and the estrogen receptor, you may achieve better control of the disease."

The Phase II study enrolled 93 women from 30 centers across the United States and Latin America, with M. D. Anderson enrolling 20 patients. All of the women were newly diagnosed with metastatic breast cancer and were hormone receptor positive and estrogen receptor HER-2 negative. Patients were randomized to receive the aromatase inhibitor Arimidex (1 milligram) and Iressa (250 milligram) daily or Arimidex and placebo. The primary endpoint was progression-free survival.

When the study was unblinded, the researchers were surprised by the distinct findings: in the women who received Arimidex and Iressa, progression-free survival was 14.5 months, compared to 8.2 months in the women who did not rece
'/>"/>

Contact: Laura Sussman
lsussman@mdanderson.org
713-745-2457
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Study shows that administering calcium and magnesium effectively reduces neurological sensitivity
2. Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial
3. Having Less Power Impairs the Mind and Ability to Get Ahead, Study Shows
4. Kids Growing Up on Grown Up Drugs: New Research Shows Treatments for Adult Ailments Rapidly Rising in Children
5. Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File
6. New Survey Shows Americans Value Oral Health But Knowledge Gap Remains
7. Research shows HPV testing offers women protection for twice as long as smear testing
8. Study shows that prostate cancer increases the risk of bone fracture
9. TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients with Diabetes Compared to Non-Diabetics in ARRIVE Registry Program
10. Mayo Clinic study shows acupuncture and myofascial trigger therapy treat same pain areas
11. Expanded food and nutrition program shows $10 benefit for each $1 spent
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Iressa shows promise for treatment of metastatic breast cancer when combined with hormonal therapy
(Date:5/6/2015)... May 06, 2015 Prime Pacific ... is excited to announce a new series of ... the industry’s carbon footprint while improving treatment efficacy ... Eco-Flex™, the world’s first waste hose ... game-changer for hydrotherapists,” claims the company’s president, Mr. ...
(Date:5/6/2015)... “ SideChef ” was featured on NewsWatch as part of its ... applications on the market for iOS, Android, and Windows. Joe Toohey, ... and shared with viewers how this application walks users through recipes. ... good navigator people had to know how to read a map? ... navigator. Well what if people could “GPS” their way through a ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 vcfo, a ... HR, IT and operational support to optimize business performance ... CFOs, Jack Lynch and Michael Scheaffer. Both Lynch and ... and leadership experience. , “We are delighted to ... Wood, vcfo CEO. “Leveraging their background in financial management ...
(Date:5/6/2015)... Healthcare jobs platform, JobMedic.com, has quickly ... The company connects hospitals, home-health, and other medical organizations ... industry. Likewise, job seekers are able to locate jobs ... unique traffic to the site is up more than ... posting brings targeted, interested candidates to the site through ...
(Date:5/6/2015)... The Alliance for Regenerative Medicine (ARM), ... advanced therapies community, today announced the release of ... look at sector trends and metrics from the ... is available online here and also ... here . , Using information provided by ...
Breaking Medicine News(10 mins):Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:vcfo Adds Two Senior Executives to Growing Team 2Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 3
... seem largely visual the preening, the coy eye contact ... voice may be a means of demonstrating attraction, says Susan ... Pa., in a study, "Vocal and Physiological Changes in Response ... in the fall by the Journal of Nonverbal Behavior ...
... ... play weather, the National Recreation and Park Association (NRPA) is reminding Americans to take the ... To assist, NRPA has published The Dirty Dozen, a comprehensive brochure and playground-safety resource ... ...
... ... Patient Satisfaction Conference June 4th 2010. Expert speakers will discuss improving communications between caregivers, ... , ... 2010 -- Scan Am Company of Algonquin, Illinois, will be hosting a Patient Safety ...
... and when they were readmitted , THURSDAY, May 20 ... disease who decide to discharge themselves before their doctors ... and when they are readmitted. , The finding, set ... for Pharmacoeconomics and Outcomes Research meeting in Atlanta, comes ...
... Gastroesophageal reflux (GER), defined as passage of gastric contents ... in healthy infants, children and adults. When GER causes ... gastroesophageal reflux disease (GERD). During infancy, GER is common ... non-specific symptoms as irritability and cough. Association of non-specific ...
... a study published today in the journal Addiction , ... effective among people with severe mental illnesses as it is ... offering such treatments does not appear to cause deterioration in ... severe mental illnesses (SMI) such as schizophrenia have some of ...
Cached Medicine News:Health News:The sound of seduction 2Health News:Spring into Summer with The Dirty Dozen Guide to Playground Safety 2Health News:Spring into Summer with The Dirty Dozen Guide to Playground Safety 3Health News:Patient Safety and Satisfaction are Key Issues at Scan Am Company June Conference 2Health News:When Heart Patients Discharge Themselves, Hospital Bills Increase 2Health News:Disagreement on symptom-reflux association analysis parameters in infants 2Health News:Smoking cessation treatments work and are safe for people with severe mental illness 2
(Date:5/6/2015)... PARIS , May 6, 2015 ... the development and manufacture of filtration products, mainly for ... ZenPure designs custom filters manufactured in a state-of-the-art plant ... are marketed and sold across the globe and will ... Plastics business. This acquisition is fully in ...
(Date:5/6/2015)... , May 6, 2015  Membership in Medicare Supplement ... a Healthcare Business Strategy report released by Mark ... as Medigap or Med Supp plans, covered approximately ... a 5.2% increase from 2013. Between 2013 and ... 551,135 covered lives.  Though UnitedHealth was the segment ...
(Date:5/6/2015)... Research and Markets ( http://www.researchandmarkets.com/research/7qn2gf/global_insulin ... "Global Insulin Patch Market Opportunity Analysis" report ... like ultrasound and iontophoresis are being used for ... the type of technique, their prices may vary ... patients. In long-term, it would be considered as ...
Breaking Medicine Technology:Saint-Gobain Acquires ZenPure, a Specialist in Filtration Products 2Continued Growth in Med Supp Market for 2014 according to Mark Farrah Associates 2Global Insulin Patch Market Opportunity Analysis 2015 2
... First Effective Drug for Rare Genetic Disorder in,Children--, ... drug to achieve normal levels of blood sugar ... levels. If this approach,succeeds in humans, it could ... a rare but potentially devastating genetic,disease in which ...
... Pathwork Diagnostics, Gene Expression Test Is the First to Receive FDA, ... ... U.S. Cancer Cases Annually, SUNNYVALE, Calif., July 31 Pathwork ... U.S. Food and Drug Administration (FDA) has cleared its Pathwork(R),Tissue of ...
Cached Medicine Technology:Treatment Corrects Severe Insulin Imbalance in Animal Studies 2Treatment Corrects Severe Insulin Imbalance in Animal Studies 3FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors 2FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors 3FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors 4